Pinnacle Wealth Management Advisory Group’s Haemonetics HAE Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$316K	Buy	+4,208	New	+$270K	0.02%	405

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's HAE Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group opened a new position in Haemonetics (HAE) in Q2 2026: 4,208 shares worth $316K. The stake represents 0.02% of the portfolio and ranks #405 among its holdings.

329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Pinnacle Wealth Management Advisory Group held 4,208 shares of Haemonetics worth $316K as of Q2 2026.
Haemonetics was a new Pinnacle Wealth Management Advisory Group position in Q2 2026.
Haemonetics made up 0.02% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #405 holding.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.